GSE140559 GSE140561 adenosine 0 v 1 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE140559_GSE140561_adenosine_0_v_1_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE140559_GSE140561_adenosine_0_v_1_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE140559_GSE140561_adenosine_0_v_1_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE140559_GSE140561_adenosine_0_v_1_human_up.

Results found

Linked to

 

Label

Description

 

Gene

H2B clustered histone 8

Gene

Rho GTPase activating protein 23

Gene

vesicle associated membrane protein 7

Gene

H19 imprinted maternally expressed transcript

Gene

small nucleolar RNA host gene 1

Gene

long intergenic non-protein coding RNA 205

Gene

FGD5 antisense RNA 1

Gene

MIR1915 host gene

Gene

DPPA2 upstream binding RNA

Gene

Morf4 family associated protein 1 like 2

  • Gene

    H2B clustered histone 8


  • Gene

    Rho GTPase activating protein 23


  • Gene

    vesicle associated membrane protein 7


  • Gene

    H19 imprinted maternally expressed transcript


  • Gene

    small nucleolar RNA host gene 1


  • Gene

    long intergenic non-protein coding RNA 205


  • Gene

    FGD5 antisense RNA 1



  • Gene

    DPPA2 upstream binding RNA


  • Gene

    Morf4 family associated protein 1 like 2

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.